Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in Recurrent Gliomas, PCNSL, and Brain Metastases
NCT00276783Phase 2Unknown
- Sponsor
- Northwestern University
- Start
- Nov 2005
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in malignant glioma, primary central nervous system lymphoma (PCNSL), brain metastases, sponsored by Northwestern University. Status: unknown.
02
Drugs
pemetrexed
03
Conditions
malignant gliomaprimary central nervous system lymphoma (PCNSL)brain metastases
Beyond the preview
Go deeper on NCT00276783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276783.